Cargando...

The Use of Risk Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-society Cholesterol Guidelines

PURPOSE OF REVIEW: In 2018, the AHA/ACC multi-society Cholesterol Guidelines introduced the novel concept of risk-enhancing factors to be used as a supplement to the pooled cohort risk equations to personalize atherosclerotic cardiovascular disease risk assessment in primary prevention. In this revi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Cardiovasc Risk Rep
Main Authors: Agarwala, Anandita, Liu, Jing, Ballantyne, Christie M., Virani, Salim S.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7451216/
https://ncbi.nlm.nih.gov/pubmed/32864034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12170-019-0616-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!